Tag: COVID-19

New Vaccine Research Highlights Infectious Disease Advances Ahead of IDWeek 2026

Pfizer will present 57 research abstracts at IDWeek 2026, highlighting vaccine research…

ME Desk

World Leaders Renew Commitment to Pandemic Prevention and Preparedness

World leaders at the UN General Assembly have renewed commitments to pandemic…

ME Desk

U.S. FDA Approves XFG-Adapted COVID-19 Vaccine for 2026โ€“2027

U.S. FDA approves the XFG-adapted 2026โ€“2027 COVID-19 vaccine from Pfizer and BioNTech…

ME Desk

Unvaccinated by Choice: A Risk to Themselves or Everyone

Vaccines have been heralded as one of the most outstanding public health…

Dr. Manu Krishna, MD

Fidson Healthcare Plc Strengthens Leadership Team with Strategic Board Appointments

February 2025- Nigeriaโ€™s pharmaceutical company, Fidson Healthcare Plc announces the appointment of…

ME Desk

AstraZeneca appoints Iskra Reic as EVP to lead international markets

December 2024- AstraZeneca announced the appointment of Iskra Reic as Executive Vice…

ME Desk

Largest-ever exome study by Mayo Clinic provides roadmap for biomedical innovation

Rochester- December 2024- Mayo Clinic's Center for Individualized Medicine has achieved a…

ME Desk

Arab Health to address MEAโ€™s US$3.29 billion wearable medical device market

Dubai, UAE- November 2024- Arab Health 2025 will explore the growth of…

ME Desk

โ€˜โ€˜Lower Costs, High-Quality Care, and Shorter Wait Times Drive Medical Tourismโ€™โ€™

Thanks to more affordable prices, higher-quality care, and greater access to specialized…

Mohammed Irshad

Could White Blood Cell issues fuel Melanoma risk?

Rochester- September 2024- About 8 to 10 million Americans over age 40…

ME Desk